Repligen (RGEN) Operating Expenses (2010 - 2026)

Repligen (RGEN) has 17 years of Operating Expenses data on file, last reported at $178.3 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 9.67% year-over-year to $178.3 million in Q1 2026; TTM through Mar 2026 was $698.8 million, a 2.36% increase from a year earlier, with the FY2025 full-year figure at $683.1 million, up 2.02% from the prior year.
• Operating Expenses for Q1 2026 stood at $178.3 million, down from $180.0 million in the prior quarter.
• Over the last five years, Operating Expenses for RGEN reached as high as $204.0 million in Q4 2024 and fell as low as $136.5 million in Q3 2023.
• Historically, Operating Expenses has averaged $158.4 million across 5 years, with a median of $153.4 million in 2024.
• Across the five-year window, Operating Expenses soared 37.52% in 2022 and decreased 11.76% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $137.9 million in 2022, then climbed by 13.65% to $156.7 million in 2023, then surged by 30.18% to $204.0 million in 2024, then retreated by 11.76% to $180.0 million in 2025, then declined by 0.96% to $178.3 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $178.3 million in Q1 2026, $180.0 million in Q4 2025, and $172.0 million in Q3 2025.